| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2851221 | American Heart Journal | 2009 | 9 Pages |
Abstract
The findings of BCIS-1 are expected to define the role of balloon counterpulsation in high-risk PCI. Confirmation of the efficacy of elective IABP use may prompt review of the international guidelines, which are currently very restricted. In contrast, a neutral or adverse outcome with elective counterpulsation in these high-risk patients will allow evidence-based rationalization of the current disparity between guidelines and the frequent real-world use of elective IABP support.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Divaka MA, MD, MRCP, Rodney DM, FRCP, Jean MS, Martyn MD, FRCP, Simon MD, FRCP, FACC, on behalf of the BCIS-1 Investigators on behalf of the BCIS-1 Investigators,